Aerie Pharmaceuticals reported $9.06M in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Aerie Pharmaceuticals AERI:US USD 9.06M 217K
Alimera Sciences ALIM:US USD 8.71M 1.09M
Amarin AMRN:US USD 93.16M 23.15M
Bluebird Bio BLUE:US USD 18.62M 6.24M
Cara Therapeutics CARA:US USD 15.22M 5.48M
Coherus Biosciences CHRS:US USD 9.92M 7.57M
Endo International Ordinary Shares ENDP:US USD 85M 5.64M
Horizon Pharma HZNP:US USD 32.11M 13.58M
Insmed INSM:US USD 11.58M 19.57M
Mirati Therapeutics MRTX:US USD 19.45M 4.82M
Novartis NOVN:VX USD 4.69B 276M
Pacira Pharmaceuticals PCRX:US USD 12.93M 1.05M
Regeneron Pharmaceuticals REGN:US USD 535.6M 1.4M
Revance Therapeutics RVNC:US USD 744K 12.53M
Supernus Pharmaceuticals SUPN:US USD 16.02M 19.5M
Teva Pharmaceutical Industries TEVA:US USD 1.64B 266M
Valeant Pharmaceuticals VRX:CN USD 486M 50M
Zoetis ZTS:US USD 373M 57M